Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Orexin receptors: Structural and anti-tumoral properties
Alain Couvineau, Pascal Nicole, Valérie Gratio, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20

Showing 20 citing articles:

The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
Polypharmacology: promises and new drugs in 2022
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 755-770
Open Access | Times Cited: 27
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 21
Orexin‐A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion
Rengzheng Huan, Jiqin Zhang, Jianhe Yue, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 9
Open Access | Times Cited: 6
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
The role of central neurotransmitters in appetite regulation of broilers and layers: similarities and differences
Kimia Mahdavi, Morteza Zendehdel, Hamed Zarei
Veterinary Research Communications (2024) Vol. 48, Iss. 3, pp. 1313-1328
Closed Access | Times Cited: 3
Unraveling the function and structure impact of deleterious missense SNPs in the human OX1R receptor by computational analysis
Mahvash Farajzadeh-Dehkordi, Ladan Mafakher, Abbas Harifi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Hypocretin-1 suppresses malignant progression of glioblastoma cells through Notch1 signaling pathway
Renzheng Huan, Jianhe Yue, Jinhai Lan, et al.
Brain Research Bulletin (2023) Vol. 196, pp. 46-58
Open Access | Times Cited: 6
Involvement of the Orexinergic System in Cancer: Antitumor Strategies and Future Perspectives
Pilar Marcos, Rafael Coveñas
Applied Sciences (2023) Vol. 13, Iss. 13, pp. 7596-7596
Open Access | Times Cited: 5
An Insight into Neuropeptides Inhibitors in the Biology of Colorectal Cancer: Opportunity and Translational Perspectives
Ankit Srivastava, Deeksha Rikhari, Biswajita Pradhan, et al.
Applied Sciences (2022) Vol. 12, Iss. 18, pp. 8990-8990
Open Access | Times Cited: 8
Synthesis of Pyrrolo[3,4-b]pyridin-5-ones via Ugi–Zhu Reaction and In Vitro–In Silico Studies against Breast Carcinoma
Ivette Morales-Salazar, Carlos E. Garduño-Albino, Flora P. Montes-Enríquez, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1562-1562
Open Access | Times Cited: 4
Regulatory effect of orexin system on various diseases through mTOR signaling pathway
Ying Song, Beibei Wang, Wenjun Wang, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 5, pp. 292-302
Open Access | Times Cited: 3
Efficiency of Orexin-A for Inflammatory Flare and Mucosal Healing in Experimental Colitis: Comparison with the Anti-TNF Alpha Infliximab
Anne Blais, Annaïg Lan, François Blachier, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9554-9554
Open Access | Times Cited: 2
Imaging flow cytometry of tumoroids: A new method for studying GPCR expression
Valérie Gratio, Stéphanie Dayot, Samira Benadda, et al.
Cytometry Part A (2023) Vol. 105, Iss. 4, pp. 276-287
Open Access | Times Cited: 2
Orexins and Prostate Cancer: State of the Art and Potential Experimental and Therapeutic Perspectives
Anna Costagliola, Renato Lombardi, Giovanna Liguori, et al.
Cancer Genomics & Proteomics (2023) Vol. 20, Iss. 6suppl, pp. 637-645
Open Access | Times Cited: 2
Revolutionizing Infertility Management through Novel Peptide-based Targets
Vijay Kumar, Gaurav Doshi
Current Protein and Peptide Science (2024) Vol. 25, Iss. 9, pp. 738-752
Closed Access
Bioinformatic analysis of neuropeptide related genes in patients diagnosed with invasive breast carcinoma
Fatih Yay, Durmuş Ayan
Computers in Biology and Medicine (2024) Vol. 183, pp. 109304-109304
Closed Access
The Aggravating Role of Failing Neuropeptide Networks in the Development of Sporadic Alzheimer’s Disease
Miklós Jászberényi, Balázs Thurzó, Arumugam R. Jayakumar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13086-13086
Open Access
Pharmacodynamics of the orexin type 1 (OX1) receptor in colon cancer cell models: A two‐sided nature of antagonistic ligands resulting from partial dissociation of Gq
Valérie Gratio, Paulina Dragan, Luis Garcı́a, et al.
British Journal of Pharmacology (2024)
Open Access
the inhibitory effect of Orexin system on different diseases through mTOR signaling pathway
Ying Song, Beibei Wang, wenjun wang, et al.
Authorea (Authorea) (2022)
Open Access
Page 1

Scroll to top